As policymakers continue to chip away at fixes to ongoing drug shortages, the FDA’s drug center head is urging manufacturers to work with FDA on inspection issues before halting production of critical medications.
During a presentation at the FDA’s joint meeting with the Parenteral Drug Association on Monday, FDA’s CDER…
Click here to view original post
